ESB Developments, a dynamic, UK-based SME, specialises in the development and commercialisation of innovative health products. The team has many years’ experience of working in the area of Vitamin and PUFA (Polyunsaturated Essential Fatty Acids) nutrition and has a strong track record in the development and commercialisation of novel products, particularly those suitable for vegans and vegetarians. ESB’s portfolio includes Opti3, an award-winning Omega-3 product suitable for vegans and a range of other unique nutrient supplement products developed specifically for non-meat eaters. In the proposed proof of concept project, ESB intends to evaluate the feasibility of developing a new source of an essential nutrient molecule utilising a novel and innovative approach. The company will work with UK-based partners to explore potential sourcing and processing options that have the potential to support rapid scale-up and launch. A successful project would have a transformative impact for ESB as it would improve both the scalability and potential capacity of this novel product. This would enable it to satisfy a significant unmet market need and to rapidly capture market share both in Europe and on a global basis. This additional revenue would catalyse further investment in UK R&D (particularly to expand on its portfolio of novel ingredients) and UK-based manufacturing facilities, including supporting staff.

ESB is dedicated to the development and commercialisation of innovative health & beauty products. Its portfolio includes Opti3, an award-winning Omega-3 product suitable for vegans and vegetarians and Vitashine, a 100% plant-based Vitamin D3 (Cholecalciferol).The company will use its innovation voucher to further develop its portfolio.